000 | 01303 a2200397 4500 | ||
---|---|---|---|
005 | 20250512193442.0 | ||
264 | 0 | _c19680119 | |
008 | 196801s 0 0 eng d | ||
022 | _a0009-9287 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLant, A F | |
245 | 0 | 0 |
_aLocalization of the site of action of oral diuretics in the human kidney. _h[electronic resource] |
260 |
_bClinical science _cAug 1967 |
||
300 |
_a11-27 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aBenzothiadiazines _xpharmacology |
650 | 0 | 4 |
_aDiuresis _xdrug effects |
650 | 0 | 4 |
_aDiuretics _xpharmacology |
650 | 0 | 4 |
_aEthacrynic Acid _xpharmacology |
650 | 0 | 4 |
_aFurosemide _xpharmacology |
650 | 0 | 4 | _aGlomerular Filtration Rate |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydroflumethiazide _xpharmacology |
650 | 0 | 4 |
_aKidney _xdrug effects |
650 | 0 | 4 |
_aKidney Tubules _xmetabolism |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNatriuresis _xdrug effects |
650 | 0 | 4 |
_aPolythiazide _xpharmacology |
650 | 0 | 4 |
_aPotassium _xmetabolism |
650 | 0 | 4 |
_aSodium _xmetabolism |
650 | 0 | 4 |
_aTriamterene _xpharmacology |
700 | 1 | _aBaba, W I | |
700 | 1 | _aWilson, G M | |
773 | 0 |
_tClinical science _gvol. 33 _gno. 1 _gp. 11-27 |
|
999 |
_c6059437 _d6059437 |